Journal article
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial
Enterovirus 71 (EV71) outbreaks are a socioeconomic burden, especially in the western Pacific region. Results of phase 1 clinical trials suggest an EV71 vaccine has a clinically acceptable safety profile and immunogenicity. The researchers aimed to assess the best possible dose and formulation, immunogenicity, and safety profile of this EV71 vaccine in healthy Chinese children.
Authors
Languages
- English
Publication year
2013
Journal
The Lancet
Volume
9871
Type
Journal article
Categories
- Vaccines & delivery devices
Countries
- China
Tags
- New vaccine introduction
- Performance monitoring
WHO Regions
- Western Pacific Region